Dr. Carole Baas became a cancer advocate following her diagnosis with breast cancer in 2004 after the birth of her second child. Carole is a YSC RISE Legacy Advocate and participated in YSC’s Research Think Tank, serving on the Pregnancy Associated Breast Cancer Working Group. She is also an Advocate in Science with Susan G. Komen; a member of the External Advisory Board for the Simmons Comprehensive Cancer Center at UT Southwestern; a patient advocate for the Breast and the Experimental Imaging Sciences Committees for ECOG-ACRIN, which is part of the National Clinical Trials Network; and a member of the Institutional Review Board at Baylor Research Institute in Dallas, Texas.
Carole also represents the patient voice as one of the four founding editors of the scientific journal Convergent Science Physical Oncology, which focuses on how experimental and theoretical science contributes to a better understanding of cancer complexity and to the development of more effective diagnostic and treatment strategies.
Previously Carole served as the national advocate for the NCI’s Physical Sciences-Oncology program, an innovative effort to encourage collaboration between physical scientists/engineers and cancer biologists/oncologists to generate novel methods to improve the diagnosis and treatment of cancer. Drawing upon her background in research and academia as well as from her personal experience with cancer—Carole has a Ph.D. in Biomedical Engineering from Texas A&M University—she worked with cross–disciplinary teams at 12 different Centers across the U.S. to develop a comprehensive advocacy program. Currently, in the second phase of the NCI program, she is an advocate with the Houston Methodist Research Institute Physical Sciences in Oncology Center.
Carole is a graduate of the National Breast Cancer Coalition’s Project LEAD (2008) and Project LEAD Clinical Trials (2010). She regularly participates as an advocate reviewer for the DoD Congressionally Directed Medical Research Program, PCORI and Komen.